Zura Bio Ltd Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by AI Biotechnology LLC, was filed 02 Mar 2026.
Zura Bio Ltd: what insiders have been doing
Zura Bio Ltd, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 24 October 2026, brought 5 filings signed by 2 insiders.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €10.6M, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €10.6M by AI Biotechnology LLC, published on 2 March 2026.
The last purchase on record was published on 2 March 2026, which is 253 days ago.
With 5 filings in twelve months, the company is quieter than the median of 24 filings across the 3,169 companies we follow on the same exchange. The full history, which starts in 2023, counts 7 purchases against 4 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists net income at -68.7 m USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -34.5%Entry US$5.50 · Close at T+90 US$3.60
- -81.8%Entry US$5.49 · Close at T+365 US$1.00
- -62.2%Entry US$3.62 · Close at T+365 US$1.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Zura Bio Ltd Strong Buy (bullish), based on 6 analysts. Average price target: US$18.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
- 50,000 shares@ US$5.75430.071% mcap30.3% of flowCommonSEC144:0001950047-26-008360
- 27,000 shares@ US$5.60530.037% mcap16.0% of flowCommonSEC144:0001950047-26-008288
- 40,000 shares@ US$5.51350.055% mcap23.3% of flowCommonSEC144:0001950047-26-008157
- 51,000 shares@ US$5.62830.071% mcap30.4% of flowCommonSEC144:0001950047-26-008110
- 2,000,000 shares@ US$6.25100.0% of flowClass A Ordinary SharesSEC:0001193125-26-085900:0Canonical exit: 27 May 2026 (T+90)
- 1,000 shares0Class A Ordinary SharesSEC:0001415889-24-030312:1
- 500 shares0Class A Ordinary SharesSEC:0001415889-24-030312:0
- 1,001,633 shares@ US$2.7313.5% of flowClass A Ordinary SharesSEC:0001415889-24-027847:0
- 3,800,000 shares@ US$2.7048.1% of flowClass A Ordinary SharesSEC:0001415889-24-023366:0
- 51,728 shares@ US$3.874.9% of flowClass A ordinary sharesSEC:0001415889-24-023032:0
- 9,860 shares@ US$6.0570.1% of flowClass A ordinary sharesSEC:0001415889-24-020979:0
- 80,000 shares@ US$6.20100.0% of flowClass A ordinary sharesSEC:0001415889-24-014179:0Canonical exit: 15 Aug 2024 (T+90)
- 3,195 shares@ US$3.13100.0% of flowClass A ordinary sharesSEC:0001415889-24-011481:0Canonical exit: 21 Jul 2024 (T+90)
- 7,987 shares@ US$3.1329.9% of flowClass A ordinary sharesSEC:0001415889-24-011482:0Canonical exit: 21 Jul 2024 (T+90)
- 159,744 shares@ US$3.1350.1% of flowClass A ordinary sharesSEC:0001415889-24-011480:0Canonical exit: 21 Jul 2024 (T+90)
- 1,186,901 shares@ US$3.1395.1% of flowClass A ordinary sharesSEC:0001415889-24-011479:0Canonical exit: 21 Jul 2024 (T+90)
- 2,000,000 shares@ US$4.0038.4% of flowClass A Ordinary SharesSEC:0001104659-23-126005:0
- 117,647 shares@ US$4.2549.9% of flowClass A Ordinary SharesSEC:0001104659-23-068206:0Canonical exit: 3 Sept 2023 (T+90)
- 492,381 shares0Class A Ordinary SharesSEC:0001104659-23-063313:0
- 114,395 shares0Class A Ordinary SharesSEC:0001104659-23-063316:0
- 162,060 shares0Class A Ordinary SharesSEC:0001104659-23-063312:0
- 550,000 shares@ US$10.4048100.0% of flowClass A Ordinary Shares, par value $0.0001 per shareSEC:0000902664-23-002357:0
- 2,337,630 sharesClass A ordinary sharesSEC:0001104659-23-035745:0
- 2,337,630 sharesClass B ordinary sharesSEC:0001104659-23-022455:0
- 2,337,630 sharesClass B ordinary sharesSEC:0001104659-23-022452:0
25 of 25 declarations
About Zura Bio Ltd
Zura Bio Ltd is a biotechnology company focused on developing innovative treatments for autoimmune diseases. It is listed on NASDAQ under the ticker symbol ZURA.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
